Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L129473-1g | 1g | In stock | $137.90 | |
L129473-5g | 5g | In stock | $343.90 | |
L129473-25g | 25g | In stock | $1,373.90 | |
L129473-100g | 100g | In stock | $3,433.90 |
Highly potent, reversible, selective aromatase inhibitor
Synonyms | letrozole|112809-51-5|Femara|4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile|Letrozol|CGS 20267|Letoval|CGS-20267|Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-|4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile|4-[(4-cyanophenyl)-(1,2,4-t |
---|---|
Specifications & Purity | 98% |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Cytochrome P450 19A1 inhibitor |
Product Description | Letrozole has been used: · in organoid growth assay to determine its inhibitory capacity(48) · to investigate steroid receptor coactivator-1 (SRC-1) mediated endogenous estrogen regulation of hippocampal PSD-95(49) · to determine its effects on tumor-induced hyperalgesia(50) · for hormonal manipulation in rats(51) · to study its effects on lipocalin-2 (Lcn2)(52) · to determine its effects on mechanical hyperalgesia and aromatase expression(53) |
ALogP | 2.7 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile |
---|---|
INCHI | InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H |
InChi Key | HPJKCIUCZWXJDR-UHFFFAOYSA-N |
Canonical SMILES | C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3 |
Isomeric SMILES | C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3 |
WGK Germany | 3 |
RTECS | DI4957000 |
PubChem CID | 3902 |
Molecular Weight | 285.303 |
CAS Registry No. | 112809-51-5 |
---|---|
DrugBank Ligand | DB01006 |
Wikipedia | Letrozole |
ChEBI | CHEBI:6413 |
PubChem CID | 3902 |
ChEMBL Ligand | CHEMBL1444 |
DrugCentral Ligand | 1556 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J2217707 | Certificate of Analysis | Aug 14, 2024 | L129473 |
J2217709 | Certificate of Analysis | Aug 14, 2024 | L129473 |
G2403545 | Certificate of Analysis | Apr 13, 2024 | L129473 |
I2319427 | Certificate of Analysis | May 25, 2023 | L129473 |
I2319428 | Certificate of Analysis | May 25, 2023 | L129473 |
I2319429 | Certificate of Analysis | May 25, 2023 | L129473 |
I2319430 | Certificate of Analysis | May 25, 2023 | L129473 |
I2319431 | Certificate of Analysis | May 25, 2023 | L129473 |
I2319436 | Certificate of Analysis | May 25, 2023 | L129473 |
I2319437 | Certificate of Analysis | May 25, 2023 | L129473 |
G2127168 | Certificate of Analysis | May 10, 2023 | L129473 |
G2127177 | Certificate of Analysis | May 10, 2023 | L129473 |
G2127170 | Certificate of Analysis | May 10, 2023 | L129473 |
J2217672 | Certificate of Analysis | Jul 26, 2022 | L129473 |
J2217689 | Certificate of Analysis | Jul 26, 2022 | L129473 |
Pictogram(s) | GHS08 |
---|---|
Signal | Danger |
Hazard Statements | H373:Causes damage to organs through prolonged or repeated exposure H360:May damage fertility or the unborn child |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P260:Do not breathe dust/fume/gas/mist/vapors/spray. P203:Obtain, read and follow all safety instructions before use. P318:if exposed or concerned, get medical advice. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
RTECS | DI4957000 |